Ashwath Jayagopal serves as Executive at Ocuphire Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Ashwath Jayagopal has executed 3 insider transactions totaling $6.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved receiving (via award) 400,000 shares valued at $0.
Ashwath Jayagopal currently holds 525,807 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ashwath Jayagopal has been a net buyer of OCUP stock. They have purchased $6.2K and sold $0 worth of shares.
Ashwath Jayagopal's most recent insider trade was on Jan 22, 2026, when they sold 400,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.77 |
| Discretionary |
| Feb 12, 2024 | OCUP | $0 | Award | 75,000 | $N/A | Discretionary |